Aims and scope
BMJ Medicine is a new open access, multispecialty journal from The BMJ. It exists to facilitate multidisciplinary collaboration and discussion, encouraging debate on controversial topics and the exchange of new knowledge and ideas to improve the health of patients and the public. Closely aligned with The BMJ, BMJ Medicine prioritises influential research, reviews and methodology papers with the potential to improve medical practice, policy, education or future studies. The journal prioritises specialist research with wider general relevance that will influence clinical care, public health policy, medical education and the direction of future research. BMJ Medicine also publishes in depth specialty reviews and articles presenting new approaches to research methodology and reporting. BMJ Medicine is committed to partnering with patients across its content. This includes promoting the co-production of research and commissioned articles and conducting patient review alongside traditional peer review. Read about BMJ Medicine‘s Editorial Team.
6 reasons to publish with us
BMJ Medicine is owned by BMJ.
Peer review modelOpen peer review
Continuous online publication
DOAJ, Google Scholar
Dryad is an international repository of data underlying peer-reviewed articles in the basic and applied biosciences. Dryad enables scientists to validate published findings, explore new analysis methodologies, repurpose data for research questions unanticipated by the original authors, and perform synthetic studies. BMJ has been working with Dryad since 2010.
The mission of OASPA is to support and represent the interests of open access journal publishers globally in all scientific, technical, and scholarly disciplines. The BMJ Publishing Group has been a member since 2009.
Open Access articles in BMJ Medicine are licensed using either Creative Commons Attribution (CC BY) or Attribution Non-Commercial (CC BY-NC) license. These licenses let others distribute, remix, tweak and build upon your work.